| Patents for C07J 17 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,111) |
|---|
| 05/14/2009 | US20090124585 Novel Crystalline Pharmaceutical Product |
| 05/13/2009 | CN101428033A Mix-configuration ginsenoside Rh2 and uses thereof |
| 05/12/2009 | US7531528 mixture of aqueous carrier liquid containing dissolved glucocorticoid and 3-oxoandrostane carbothioic coompound |
| 05/07/2009 | US20090118495 Process for the Preparation of 6-alpha,9-alpha-difluoro-17-alpha-((2-furanylcarbonyl)oxy)-11-beta-hydroxy-16-alpha-methyl-3-oxo-androsta-1,4-diene-17-beta- -carbothioic acid S-fluoromethyl |
| 05/06/2009 | EP2054071A1 Process for preparing a composition comprising steroidal glycosides |
| 05/06/2009 | CN100484953C Pseudoginsenoside-Pdq and its semi-synthesis process and medicine use |
| 04/23/2009 | US20090105163 Conjugates of Immune Cell Specific Macrolide Compounds with Anti-Inflammatory Compounds for Improved Cellular Targeting of Anti-Inflammatory Therapy |
| 04/22/2009 | EP1551865B1 Hybrid molecules of macrolides with steroidal/non-steroidal anti-inflammatory molecules |
| 04/15/2009 | CN101407535A Preparation of high-purity Momordica grosvenori mogroside V |
| 04/15/2009 | CN100478352C Hapten-marked peptides |
| 04/08/2009 | CN101402665A Process for producing momordica grosvenori glycoside V |
| 04/02/2009 | US20090088412 withanolide compounds extracted from a Solanaceae plant as anticancer agents; solvent extraction from Tubocapsicum anomalum |
| 04/01/2009 | CN101397327A Method for preparing dihydro ginsenoside Rg2 and use thereof |
| 04/01/2009 | CN101397326A Ginsenoside Rb1 containing impurity ginsenoside Rg2 |
| 04/01/2009 | CN101396555A Methods and compositions for interferon therapy |
| 04/01/2009 | CN100473661C Novel dammarane sapogenins, use thereof as anti-cancer agents, and a process for producing the same |
| 03/26/2009 | US20090082318 Deuterium-enriched mometasone |
| 03/25/2009 | CN101392013A Ginsenoside Rb1 containing impurity ginsenoside Rh1 |
| 03/19/2009 | US20090075913 Glycoside having 4-methylergost-7-en-3-ol skeleton and hyperglycemia improving agent |
| 03/11/2009 | CN101381397A Microwave extraction method of steroid saponin from puncturevine |
| 03/05/2009 | US20090062526 novel method of synthesizing alkylated bile acid derivatives |
| 03/05/2009 | US20090062217 Promoter For The Production Of Hyaluronic Acid Containing Ginsenoside Compound K |
| 03/04/2009 | CN100465187C Upright datura flower steroid-lactone components, and a preparation and a pharmaceutical in antitumour medicines |
| 03/03/2009 | US7498321 17β-carbothioate 17α-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/26/2009 | WO2009023975A2 Novel sweetener iso-mogroside v |
| 02/25/2009 | CN101374854A Process for production of steroids |
| 02/25/2009 | CN101374571A Na/K-ATPase ligand |
| 02/11/2009 | CN101362790A Starfish saponins antineoplastic compounds |
| 02/11/2009 | CN100459987C Effective part of astragalus, preparing method and application in pharmacy |
| 01/22/2009 | US20090023666 Modulators of Hypoxia Inducible Factor-1 and Related Uses |
| 01/21/2009 | CN101348515A Use of starfish saponin compound |
| 01/21/2009 | CN101348514A Use of starfish saponin compound extracted from Culcita novaeguineae |
| 01/20/2009 | CA2304770C A use of steroidal saponins for the prophylaxis or treatment of dementia, and novel steroidal saponin compounds |
| 01/14/2009 | CN101343305A Preparation method for astragaloside |
| 01/08/2009 | US20090012277 Process for Preparation of Timosaponin B II |
| 01/08/2009 | US20090012013 Steroid modified solatrioses |
| 01/06/2009 | CA2412541C 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-.beta.-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 01/06/2009 | CA2113819C Novel glycoside compounds and production and use thereof |
| 01/01/2009 | US20090005324 Biologically active extract from dendrobium plant, use thereof and process for preparing the same |
| 12/25/2008 | US20080317833 Novel Anti-Inflammatory Androstane Derivatives |
| 12/24/2008 | WO2008137599A3 2-alkoxyestradiol analogs and pharmaceutical preparations |
| 12/17/2008 | CN101323635A Panax notoginseng saponins ST-4, and medicinal composition, preparation and use thereof |
| 12/17/2008 | CN101323634A Induced nuclear receptor TR3 expressed cardiac glycoside compounds and use thereof |
| 12/16/2008 | US7465753 hydrophobic drug having (a) glycoside like GlcNAc-Gal-, GlcNAc-Gal-Glc-, Fuc-Gal-, Gal-Glc-, as sugar moiety (b) phosphatidylcholines (c) stearylamine or oleylamine; composition improves the low solubility of gylcoside; cholestenol glycoside anticancer drug; improved drug delivery |
| 12/10/2008 | CN100441192C Use of mometasone furoate for treating airway nassage and lung diseases |
| 12/04/2008 | WO2008127381A3 Artemisinin derivatives |
| 12/04/2008 | US20080300228 Crystalline Rostafuroxin |
| 12/03/2008 | EP1305330B1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents |
| 11/27/2008 | DE19752398B4 Ein Verfahren zur Zubereitung von Metaboliten der Ginseng-Saponine A process for the preparation of metabolites of ginseng saponins |
| 11/26/2008 | EP1994081A1 Novel poly(ethylene oxide)-block-poly(ester) block copolymers |
| 11/26/2008 | EP1993672A2 Na/k-atpase ligand |
| 11/13/2008 | WO2008136199A1 Process for producing withanolide |
| 11/05/2008 | EP1223941B1 Therapeutic treatments for blood cell deficiencies using sreroids |
| 11/04/2008 | US7446097 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 10/30/2008 | WO2007070598A2 Nucleotide and oligonucleotide prodrugs |
| 10/29/2008 | EP1985621A1 Process for production of steroids |
| 10/29/2008 | CN100429220C Methods and compositions for interferon therapy |
| 10/28/2008 | CA2167321C Reagents and methods for the detection and quantification of testosterone in fluid samples |
| 10/23/2008 | WO2008127381A2 Artemisinin derivatives |
| 10/15/2008 | CN101288027A Low activation energy dissolution modification agents for photoresist applications |
| 10/15/2008 | CN101284858A Panaxadiol saponin microbial conversion products and method for preparing same |
| 10/01/2008 | CN101277705A Agent for amelioration of insulin resistance |
| 09/25/2008 | US20080234221 Transferring agent into cells; using polypeptides, polynucleotides, antibodies nucleic acids ; tumor suppressor gene; anticancer agents |
| 09/24/2008 | CN101272795A Agent for amelioration of insulin resistance |
| 09/18/2008 | WO2008109936A1 Steroidal compounds |
| 09/17/2008 | EP1969090A2 Biodiesel production processes and biodiesel produced therefrom |
| 08/28/2008 | WO2008102716A1 Agent for treatment of adhd-related diseases |
| 08/26/2008 | US7417140 17 beta -Hydroxy-7 alpha -(2'-hydroperoxy-2'-methoxyacetyl)pregna-4,9(11)-dien-3-one-21-carboxylic acid, gamma -lactone chemical intermediate useful to prepare eplerenone a hypotensive agent, useful for treating congestive heart failure |
| 08/26/2008 | CA2333669C 17.beta.-amino and hydroxylamino-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 08/19/2008 | US7414127 7 α-Enedione-substituted steroid compounds |
| 08/13/2008 | CN101240005A Method for preparing platycodin D from balloon-flower root and application thereof in anti-cancer medicament |
| 08/13/2008 | CN101240004A Technique for preparing eleutheroside B |
| 08/13/2008 | CN101239090A Pharmaceutical compositions having appetite suppressant activity |
| 08/13/2008 | CN101239089A Pharmaceutical compositions having appetite suppressant activity |
| 08/12/2008 | US7411062 17-Beta -hydroxy-7-alpha-(2'-oxoacetyl or alkanoylcarbonyl)-pregna-4,9(11)-dien-3-one-21-carboxylic acid, gamma -lactone; intermediate for preparing eplerenone |
| 08/06/2008 | EP1951738A2 Further crystalline forms of rostafuroxin |
| 07/29/2008 | US7405206 Administering by inhalation; antiinflammatory agents, antiallergens; skin disorders; reacting androstane compound with 2-oxofuran compound |
| 07/22/2008 | CA2417825C 6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 07/17/2008 | US20080171863 Reacting fluorine salt containing radioactive fluorine-18 with alkyl halide or alkyl sulfonate in presence of alcohol; decreased reaction time; high yield; reduces the formation of side products |
| 07/15/2008 | CA2245637C Antipsoriatic nail polish |
| 07/03/2008 | WO2008078362A1 Antitumor agent and food containing the same |
| 07/02/2008 | EP1938149A2 Low activation energy dissolution modification agents for photoresist applications |
| 07/02/2008 | EP1937289A2 Compositions and methods comprising panax species |
| 07/02/2008 | CN101212979A 内脏脂肪蓄积抑制剂 The visceral fat accumulation inhibitor |
| 06/26/2008 | US20080153762 Removing the plants from the soil leaving the intact plants to cure for a period of at least 1 day, cutting up the cured plants, further drying the cut plants, to obtain dried plant material comprising the steroidal glycoside; used in the management of body weight or in the dietary control of obesity |
| 06/25/2008 | EP1395604B1 Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives |
| 06/25/2008 | CN101205247A Method for preparing panaxoside monomer Re,Rh1,Rh2,Rg2,Rg3 by using ginseng stem and leaves |
| 06/18/2008 | EP1301526B1 Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid |
| 06/11/2008 | EP1930014A1 Agent for amelioration of insulin resistance |
| 06/11/2008 | EP1930013A1 Agent for amelioration of insulin resistance |
| 06/11/2008 | EP1928470A2 Modulators of hypoxia inducible factor-1 and related uses for the treatment of ocular disorders |
| 06/11/2008 | CN101195649A Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi |
| 06/10/2008 | CA2259981C 6,7-oxygenated steroids and uses related thereto |
| 06/04/2008 | EP1927361A1 Visceral fat accumulation inhibitor |
| 05/22/2008 | US20080119416 pregnane or androstane steroids for use in methods of prevention, alleviation or treatment of CNS disorders, nervous system disorders |
| 05/15/2008 | US20080113043 Method for producing ginseng fruit and ginseng flower stalk with high content of ginsenoside |
| 05/14/2008 | CN101177445A Novel bufadienolide compound as well as preparation method and uses thereof |
| 05/02/2008 | WO2007039346A3 Low activation energy dissolution modification agents for photoresist applications |
| 04/30/2008 | EP1444248B1 Novel anti-inflammatory androstane derivatives - 17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha |
| 04/24/2008 | WO2008047149A1 Pharmaceutical compositions and nasal spray incorporating anhydrous mometasone furoate |